DE60309850D1 - Cg8327 und srm in der regulation von energie-homeostase - Google Patents

Cg8327 und srm in der regulation von energie-homeostase

Info

Publication number
DE60309850D1
DE60309850D1 DE60309850T DE60309850T DE60309850D1 DE 60309850 D1 DE60309850 D1 DE 60309850D1 DE 60309850 T DE60309850 T DE 60309850T DE 60309850 T DE60309850 T DE 60309850T DE 60309850 D1 DE60309850 D1 DE 60309850D1
Authority
DE
Germany
Prior art keywords
energy homeostasis
srm
regulation
proteins
triglycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60309850T
Other languages
English (en)
Other versions
DE60309850T2 (de
Inventor
Karsten Eulenberg
Arnd Steuernagel
Thomas Haeder
Guenter Broenner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Develogen AG
Original Assignee
Develogen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Develogen AG filed Critical Develogen AG
Application granted granted Critical
Publication of DE60309850D1 publication Critical patent/DE60309850D1/de
Publication of DE60309850T2 publication Critical patent/DE60309850T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE60309850T 2002-03-14 2003-03-14 Cg8327 und srm in der regulation von energiehomeostase Expired - Fee Related DE60309850T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP02005882 2002-03-14
EP02005882 2002-03-14
EP02006012 2002-03-15
EP02006012 2002-03-15
EP02006271 2002-03-20
EP02006271 2002-03-20
EP02006810 2002-03-25
EP02006810 2002-03-25
PCT/EP2003/002714 WO2003075945A2 (en) 2002-03-14 2003-03-14 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis

Publications (2)

Publication Number Publication Date
DE60309850D1 true DE60309850D1 (de) 2007-01-04
DE60309850T2 DE60309850T2 (de) 2007-07-05

Family

ID=27808686

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60309850T Expired - Fee Related DE60309850T2 (de) 2002-03-14 2003-03-14 Cg8327 und srm in der regulation von energiehomeostase

Country Status (7)

Country Link
US (1) US20050119206A1 (de)
EP (1) EP1492553B1 (de)
JP (1) JP2005519947A (de)
AT (1) ATE345807T1 (de)
AU (1) AU2003227071A1 (de)
DE (1) DE60309850T2 (de)
WO (1) WO2003075945A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005040804A1 (en) * 2003-10-15 2005-05-06 Roche Diagnostics Gmbh Use of protein spee as a marker for breast cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780512B1 (fr) * 1998-06-25 2003-10-17 Lipha Utilisation de recepteurs de la famille rev-erb pour le criblage de substances utiles dans le traitement des dysfonctionnements du metabolisme lipidique
AU5243299A (en) * 1998-07-29 2000-02-21 Tularik Inc. Uncoupling protein-2(hcp2): compositions and methods of use
DE60028054T2 (de) * 1999-09-08 2006-12-21 Genentech, Inc., South San Francisco Fibroblasten-wachstumsfaktor-19 (fgf-19) nukleinsäure und polypeptide und verfahren zu deren verwendung für behandlung von fettleibigkeit
WO2001066706A1 (en) * 2000-03-03 2001-09-13 Human Genome Sciences, Inc. Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
WO2001096371A2 (en) * 2000-06-16 2001-12-20 Develogen Ag Adipose-related gene
US20020048581A1 (en) * 2000-07-18 2002-04-25 King George L. Modulation of nitric oxide synthase by PKC
DE10037759A1 (de) * 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
CN1525818A (zh) * 2000-12-12 2004-09-01 ��ϣŵ 用于治疗骨性关节炎及软骨修复的亚精胺合酶抑制剂

Also Published As

Publication number Publication date
EP1492553A2 (de) 2005-01-05
US20050119206A1 (en) 2005-06-02
DE60309850T2 (de) 2007-07-05
JP2005519947A (ja) 2005-07-07
ATE345807T1 (de) 2006-12-15
WO2003075945A3 (en) 2004-10-14
EP1492553B1 (de) 2006-11-22
AU2003227071A1 (en) 2003-09-22
WO2003075945A2 (en) 2003-09-18
AU2003227071A8 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
EA200600336A1 (ru) Пиперазин с or-замещенной фенильной группой и его применение в качестве ингибиторов glyt1
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE602005013811D1 (de) Behandlung von fettsucht und verbundenen erkrankungen
SI1615952T1 (sl) Metoda zdravljenja vnetnih bolezni z uporabo specifičnih veznih sredstev humanega angiopoetin
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
DE60309850D1 (de) Cg8327 und srm in der regulation von energie-homeostase
WO2003066086A3 (en) Proteins involved in the regulation of energy homeostatis
ATE545428T1 (de) Pik4cb involviert in der regulierung des energiestoffwechsels
NO20033541L (no) Anvendelse av fosfodiesteraseinhibitorer av type 4 ved hjertemuskelsykdommer
WO2003074078A3 (en) Cg3842 homologous proteins involved in the regulation of energy homeostasis
WO2004035082A3 (en) Proteins involved in the regulation of energy homeostasis
ATE412903T1 (de) Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten
WO2004050007A3 (en) Mammalian bt-42 proteins involved in the regulation of energy homeostasis
WO2003103704A3 (en) PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS
WO2003092715A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004020465A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004047855A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004016641A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004064856A3 (en) Proteins involved in the regulation of energy homeostasis
WO2003084566A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004002513A3 (en) Proteins involved in the regulation of energy homeostasis
NO20062316L (no) Nye CXCL8 antagonister
WO2003066087A3 (en) Kinases involved in the regulation of energy homeostasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee